Watch Livestream


Thursday 8th of December 4:00pm-6:00pm CET
Refreshments available from 3:30pm CET


Oslo Science Park - Meeting Room: Fauna
Gaustadalléen 21, Oslo, Norway

If you can't attend in person, join us via Livestream at


  • Highlights from the 2022 IDF Congress in Lisbon: Akhtar Hussain, President IDF
  • Living with diabetes: Arve Juritzen, Publisher
  • Brief background to InsuLife's technology: Kenneth Kirby, InsuLife Board of Directors, Transdermal Delivery Solutions Inc.
  • Transdermal absorption of medicines and skin irritation studies: Professor Howard Maybach, InsuLife Advisory Board
  • Health industry in Norway - a growth area: Karita Bekkemellem, CEO NHO Geneo
  • InsuLife operational update: Åge Nærdal, InsuLife CEO
  • Q&A

If you plan on attending in person please register by sending us an email to
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved